Benkirane M, Bonhomme M, Morsy H, Safgren SL, Marelli C, Chaussenot A, Smedley D, Cipriani V, de Sainte-Agathe JM, Ding C, Larrieu L, Vestito L, Margot H, Lesca G, Ramond F, Castrioto A, Baux D, Verheijen J, Sansa E, Giunti P, Haetty A, Bergougnoux A, Pointaux M, Ardouin O, Van Goethem C, Vincent MC, Hadjivassiliou M, Cossée M, Rouaud T, Bartsch O, Freeman WD, Wierenga KJ, Klee EW; Genomic England Research Consortium; Vandrovcova J, Houlden H, Debant A, Koenig M. De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity. Brain 2024. 17:awae193.
Canet G, Gratuze M, Zussy C, Bouali ML, Diaz SD, Rocaboy E, Laliberté F, El Khoury NB, Tremblay C, Morin F, Calon F, Hébert SS, Julien C, Planel E. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice. Neurobiol Dis 2024. 198:106526.
Carles A, Freyssin A, Perin-Dureau F, Rubinstenn G, Maurice T. Targeting N-methyl-D-aspartate receptors in neurodegenerative diseases. Int J Mol Sci. 2024; 25, 3733.
Carles A,* Hoffmann M,* Scheiner M, Crouzier L, Bertrand-Gaday C, Chatonnet A, Decker M, Maurice T. The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease. CNS Neurosci Ther 2024. 30(6):e14814.
Coste J, Robine JM, Van Oyen H, Carcaillon-Bentata L. Metrological performances of the global chronic morbidity indicator of the Minimum European Health Module and implications for chronic disease prevalence and socioeconomic gradient estimations. Eur J Public Health. 2024; 29:ckae064.
Cresto N, Givalois L, Badaut J, Janvier A, Genin A, Audinat E, Brewster AL, Marchi N. Bursts of brain erosion: seizures and age-dependent neurological vulnerability. Trends Mol Med 2024. S1471-4914(24)00304-6.
Crouzier L, Meunier J, Carles A, Morilleau A, Vrigneau C, Schmitt M, Bourguignon JJ, Delprat B, Maurice T. Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties. Phytother Res 2024. 38(2):694-712.
Freyssin A, Carles A, Guehairia S, Rubinstenn G, Maurice T. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease. Neuropharmacology 2024. 242:109733.
Freyssin A, Carles A, Moha B, Rubinstenn G, Maurice T. Long-term treatment with Fluoroethylnormemantine (FENM) alleviated memory deficits, amyloid pathology and microglial reaction in APP/PS1 mice. ACS Pharmacol Transl Sci 2024. 7(12):4069-4082
García-Pupo L, Crouzier L, Bencomo-Martínez A, Meunier J, Morilleau A, Delprat B, Sablón Carrazana M, Menéndez Soto del Valle R, Maurice T,* Rodríguez-Tanty C.* Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein. Acta Pharmaceut Sinica B 2024. 14(10):4345-4359.
Gerber YN, Perrin FE. In vivo astrocyte reprogramming following spinal cord injury. Neural Regen Res 2024;19, 487-488.
Kacher R, Lejeune FX, David I, Boluda S, Coarelli G, Leclere-Turbant S, Heinzmann A, Marelli C, Charles P, Goizet C, Kabir N, Hilab R, Jornea L, Six J, Dommergues M, Fauret AL, Brice A, Humbert S, Durr A. CAG repeat mosaicism is gene specific in spinocerebellar ataxias. Am J Hum Genet 2024. 2;111(5):913-926.
Marelli C, Ramond F, Vignal C, Blanchet C, Frost S, Hao Q, Bocquet B, Nadjar Y, Leboucq N, Taieb G, Benkirane M, Hersent C, Koenig M, Meunier I. Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia. J Neurol 2024. 271(9):6038-6044.
Méreaux JL, Davoine CS, Pellerin D, Coarelli G, Coutelier M, Ewenczyk C, Monin ML, Anheim M, Le Ber I, Thobois S, Gobert F, Guillot-Noël L, Forlani S, Jornea L, Heinzmann A, Sangare A, Gaymard B, Guyant-Maréchal L, Charles P, Marelli C, Honnorat J, Degos B, Tison F, Sangla S, Simonetta-Moreau M, Salachas F, Tchikviladzé M, Castelnovo G, Mochel F, Klebe S, Castrioto A, Fenu S, Méneret A, Bourdain F, Wandzel M, Roth V, Bonnet C, Riant F, Stevanin G, Noël S, Fauret-Amsellem AL, Bahlo M, Lockhart PJ, Brais B, Renaud M, Brice A, Durr A. Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. EBioMedicine. 2024; 99:104931.
Micheau J, Catheline G, Barse E, Hiba B, Marcilhac A, Allard M, Platt B, Riedel G. PLB2Tau mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI. Brain Res Bull 2024. 220:111161.
Notartomaso S, Antenucci N, Mazzitelli M, Rovira X, Boccella S, Ricciardi F, Liberatore F, Gomez-Santacana X, Imbriglio T, Cannella M, Zussy C, Luongo L, Maione S, Goudet C, Battaglia G, Llebaria A, Nicoletti F, Neugebauer V. A 'double-edged' role for type-5 metabotropic glutamate receptors in pain disclosed by light-sensitive drugs. Elife 2024. 13:e94931.
Otaegui L, Lehoux J, Martin L, Givalois L, Durand T, Desrumaux C, Crauste C. Overview of alkyl quercetin lipophenol synthesis and its protective effect against carbonyl stress involved in neurodegeneration. Org Biomol Chem. 2024; 22:2877-2890.
Patergnani S, Bataillard MS, Danese A, Alves S, Cazevieille C, Valero R, Tranebjaerg L, Maurice T, Pinton P, Delprat B, Richard EM. The Wolfram-like variant WFS1E864K destabilizes MAM and compromises autophagy and mitophagy in human and mice. Autophagy. 2024 23:1-12.
Poulen G, Gélisse P, Chan-Seng E, Moser PO, Genton P, Crespel A, Coubes P. Globus pallidus internus (GPi) neuromodulation is not effective in Unverricht-Lundborg disease to control myoclonia. Mov Disord. 2024 9:2354-2364
Poulen G, Chan-Seng E, Sanrey E, Coubes P. A case of successful pallidal deep brain stimulation in ANO3 dystonia. Mov Disord. 2024; 39:1071-1072
Poulen G, Mercedes-Alvarez B, Rigau V, Coubes P. Bilateral periventricular nodular heterotopia and cortical dysplasia due to filamin 1 gene mutation: An invasive EEG exploration and histopathologic study. Epileptic Disord 2024. 26(2):240-243.
Poulen G, Perrin FE. Advances in spinal cord injury: insights from non-human primates. Neural Regen Res. 2024;19:2354- 2364.
Richard ÉM, Delprat B. L’administration locale d’un vecteur AAV-TMPRSS3 à un âge avancé corrige le déficit auditif progressif dans un modèle murin de la surdité DFNB8 [Local administration of an AAV-TMPRSS3 vector in aged Tmprss3 mutant mice with progressive deafness restores hearing]. Med Sci (Paris) 2024. 40(5):402-404.
Tarot P, Lasbleiz C, Liévens JC. NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality. Neural Regen Res. 2024;19, 1006-1012.
Veyrunes F, Perez J, Heitzmann LD, Saunders PA, Givalois L. Hormone profiles of the African pygmy mouse Mus minutoides, a species with XY female sex reversal. J Exp Zool A Ecol Integr Physiol. 2024; 341:130-137.
